160
Views
8
CrossRef citations to date
0
Altmetric
Original

Radiation protocols determine acute graft-versus-host disease incidence after allogeneic bone marrow transplantation in murine models

, , , , &
Pages 625-636 | Received 08 Jul 2006, Accepted 25 Jun 2007, Published online: 03 Jul 2009
 

Abstract

Purpose: Effects of radiation sources used for total body irradiation (TBI) on Graft-versus-Host Disease (GvHD) induction were examined.

Materials and methods: In a T cell receptor (TCR) transgenic mouse model, single fraction TBI was performed with different radiation devices (60Cobalt; 137Cesium; 6 MV linear accelerator), dose rates (0.85; 1.5; 2.9; 5 Gy/min) and total doses before allogeneic bone marrow transplantation (BMT). Recipients were observed for 120 days. Different tissues were examined histologically.

Results: Acute GvHD was induced by a dose rate of 0.85 Gy/min (60Cobalt) and a total dose of 9 Gy and injection of 5×105 lymph node cells plus 5×106 bone marrow cells. Similar results were obtained using 6 MV linear accelerator- (linac-) photons with a dose rate of 1.5 Gy/min and 0.85 Gy/min, a total dose of 9.5 Gy and injection of same cell numbers. TBI with 137Cesium (dose rate: 2.5 Gy/min) did not lead reproducibly to lethal acute GvHD.

Conclusions: Experimental TBI in murine models may induce different immunological responses, depending on total energy, total single dose and dose rate. GvHD might also be induced by TBI with low dose rates.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.